Harlan F Weisman
CIK 1555563 · President and CEO · last filed 2024-07-08
Harlan F Weisman is a President and CEO who has filed 14 SEC Form 4 insider transactions across 2 companies since 2013. The most recent filing, for TFFP, was dated Jul 8, 2024. Across all open-market trades the lifetime net is +$600.0K, making them a net buyer over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
2
14
$600.0K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TFF Pharmaceuticals, Inc. (TFFP) Delisted | President and CEO | 842,095 | $0.07 | $54.7K | $409.9K | 11 | 2024-07-08 |
| Fortress Biotech, Inc. (CNDO) Delisted | Chairman and CEO | 30,000 | — | — | $190.1K | 3 | 2013-06-21 |
Recent Filings
14 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-07-08 | TFF Pharmaceuticals, Inc. (TFFP) Delisted | Grant (A) | +27,480 | $0 | EDGAR |
| 2024-04-22 | TFF Pharmaceuticals, Inc. (TFFP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-08-15 | TFF Pharmaceuticals, Inc. (TFFP) Delisted | Buy (P) | +600,000 | $150.0K | EDGAR |
| 2023-03-13 | TFF Pharmaceuticals, Inc. (TFFP) Delisted | Buy (P) | +150,000 | $131.8K | EDGAR |
| 2022-12-19 | TFF Pharmaceuticals, Inc. (TFFP) Delisted | Buy (P) | +50,000 | $53.0K | EDGAR |
| 2022-12-06 | TFF Pharmaceuticals, Inc. (TFFP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-05-20 | TFF Pharmaceuticals, Inc. (TFFP) Delisted | Buy (P) | +7,115 | $38.2K | EDGAR |
| 2022-05-17 | TFF Pharmaceuticals, Inc. (TFFP) Delisted | Buy (P) | +2,500 | $11.8K | EDGAR |
| 2020-08-26 | TFF Pharmaceuticals, Inc. (TFFP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-12-03 | TFF Pharmaceuticals, Inc. (TFFP) Delisted | Grant (A) | — | $0 | EDGAR |